Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis

Stroke

Volumn 36, Issue 6, 2005, Pages 1178-1183

  Dick, Petra ^a   Sherif, Camillo ^a   Sabeti, Schila ^a   Amighi, Jasmin ^a   Minar, Erich ^a   Schillinger, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Carotid arteries; Gender; Outcome

Indexed keywords

AGE; AGED; AMERICAN SOCIETY OF ANESTHESIOLOGISTS SCORE; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FATALITY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INTERNAL CAROTID ARTERY; INTERNAL CAROTID ARTERY OBSTRUCTION; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; STROKE; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CEREBROVASCULAR ACCIDENT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 20444401480     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000166056.04922.f2     Document Type: Article

References (26)

1. Shae LJ, Lewis JF, Hlatky MA, Hsueh WA, Kelsey SF, Klein R, Manolio TA, Sharrett AR, Tracy RP; National Heart, Lung and Blood Institute; American College of Cardiology Foundation. Gender-related risk factors for ischemic heart disease. Circulation, 2004;109:e56-e58.
2. Stensland-Bugge E, Bonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis. 2001;154: 437-448.
3. Barret-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 1997; 95:252-264.
4. Mendelson ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
5. Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB. Postmenopausal hormone therapy and risk for stroke: the Heart and Estrogen/progestin Replacement Study (HERS). Circulation. 2001;103:638-642.
6. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Grouse JR, Stein E, Cushman M; Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523-534.
7. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
8. Grodstein F, Manson JE, Stampfer MJ. Postmenopausal hormone use and secondary prevention of coronary events in the Nurse's Health Study: a prospective observational study. Ann Intern Med. 2001;135:1-8.
9. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J. 2002;23:1738-1752.
10. Rosano GMC, Sarrel PM, Poole-Wilson PA, Reitsma PH, Bertina RM, Briet E. Beneficial effects of oestrogen on exercise induced myocardial ischemia in women with coronary artery disease. Lancet. 1993;342: 134-139.
11. Reis SE, Holubkov R, Young JB, White BG, Conn JN, Feldman AM. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies. J Am Coll Cardiol. 2000;36:529-533.
12. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D; European BIOMED Study of Stroke Care Group. Sex differences in the clinical presentation, resource use, and 3-months outcome of acute stroke in Europe. Data from a multicenter multinational hospital-based registry. Stroke. 2003;34: 1114-1119.
13. Iemolo F, Martiniuk A, Steinman DA, Spence JD. Sex differences in carotid plaque and stenosis. Stroke. 2004;35:477-481.
14. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/Am College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
15. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J. Holleran R, Eberle R, Hertzberg V, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20: 864-870.
16. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
17. Love BB, Grover-McKay M, Biller J, Rezai K, McKay CR. Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke. 1992;23:939-945.
18. Norris JW, Zhu CZ, Bernstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke. 1991;22:1485-1490.
19. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, Thomas D; MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet. 2004;363:1491-1502.
20. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic. JAMA. 1995;273:1421-1428.
21. Schulz UG, Rothwell PM. Sex differences in carotid bifurcation anatomy and the distribution of atherosclerotic plaque. Stroke. 2001;32: 1525-1531.
22. Schulz UG, Rothwell PM. Major variation in carotid bifurcation anatomy: a possible risk factor for stroke. Stroke. 2001;32:2522-2529.
23. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham study. Stroke. 1982;13: 290-295.
24. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med. 1978;299:53-59.
25. Ferguson GG, Eliasziw W, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC, Barnett HJ for the NASCET Collaborators. The North American Symptomatic Carotid Endarterectomy Trial. Surgical results in 1415 patients. Stroke. 1999;30: 1751-1758.
26. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV. Sex differences and similarities in the management and outcome of stroke patients. Stroke. 2000;31:1833-1837.